Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13087404 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL678279 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL28788298 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL29090621 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL432874 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL75414 | 0.77 | PTGS1 (0.46) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL7092900 | 0.77 | ALDH1A1 (0.39) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL28292361 | 0.77 | PTGS1 (0.46) | ALDH1A1TSHRHSD17B10TDP1LMNA | |
| SCHEMBL6096493 | 0.76 | — | — | |
| SCHEMBL6096311 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0301474-B1 | NEW CYSTEINE DERIVATIVES HAVING EXPECTORANT ACTIVITY | MAGIS FARMACEUTICI S.P.A. (IT) | 1993-09-29 | — | — | EP | claimed |
| WO-2004111041-A1 | PYRROLIDINE, THIAZOLIDINE AND OXAZOLIDINE COMPOUNDS WHICH INHIBIT DIPEPTIDYL PEPTIDASE-IV (DPP) | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-12-23 | — | — | WO | disclosed |